Long-term survival and prognostic factors in endometrial cancer - a populationbased cohort study
Abstract
Aims: The over-all aims of this thesis were to evaluate the associations between
prognostic factors and excess mortality rate, between socioeconomic and immigrant
status and incidence rate, in endometrioid (EEC) and non-endometrioid (NEC)
endometrial carcinoma.
Material and methods: Study I-III were retrospective population-based cohort
studies including women resident in a defined geographical area, with endometrial
carcinoma. Data on clinicopathological variables were collected from the Western
Swedish Healthcare Region Clinical Registry for Endometrial Cancer and the Swedish
Quality Registry of Gynecologic Cancer. In study III, data on education and
immigrant status were collected from the Swedish Registry of Education and the
Statistics Sweden Population Registry.
Results: Cohort 2, had a decreased excess mortality rate compared to cohort 1,
EMRR 0.62 (95% CI 0.44-0.87) in the NEC group. There was a significant difference
in distribution of treatment in cohort 2 (p<0.001), with increased adjuvant
chemotherapy in combination with radiotherapy. Excess mortality was not increased
with presence of P53 overexpression, EMRR 1.53 (95% CI 0.79-2.97), s-phase
fraction >8%, EMRR 1.31 (95% CI 0.68-2.53), and aneuploidy, EMRR 1.79 (95% CI
0.89-3.24). In aneuploidy stage I, grade 2, 5-year relative survival was 0.88 (95% CI
0.78-0.96). Women, aged 50-74-years, with low level of education had higher
incidence rate of stage II and III-IV EEC, IRR 1.65 (95% CI 1.13-2.42) and IRR 1.82
(1.33-2.49) compared to high level of education.
Conclusions: Clinical protocol used in cohort 2, NEC, was associated with decreased
excess mortality. We did not find P53 overexpression, s-phase fraction >8% or
aneuploidy associated with increased excess mortality although aneuploidy identified
women with impaired survival in stage I grade 2. Lower level of education was
associated with increased incidence rates of stage II-IV EEC in 50-74-year-old
women.
Parts of work
I. Svanvik T, Sundfeldt K, Strömberg U, Holmberg E, Marcickiewicz J.
Population-based cohort study of the effect of endometrial cancer classification and treatment criteria on long-term survival. Int J Gynecol Obstet 2017; 138:
183-189. ::PMID::28504819 II. Svanvik T, Strömberg U, Holmberg E, Marcickiewicz J, Sundfeldt K. DNA
ploidy status, s-phase fraction, and p53 are not independent prognostic factors for survival in endometrioid endometrial carcinoma FIGO stage I-III. Int J Gynecol Cancer. 2019 Jan 2013 ::PMID::30636711 III. Svanvik T, Marcickiewicz J, Sundfeldt K, Holmberg E, Strömberg U.
Sociodemographic disparities in stage-specific incidences of endometrial cancer: A registry-based study in west Sweden, 1995-2016. ::PMID::30849264
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Clinical Sciences. Department of Obstetrics and Gynecology
Disputation
Fredagen den 5 april 2019, kl 9.00, Hjärtat, Sahlgrenska Universitetssjukhuset, Vita stråket 12, Göteborg
Date of defence
2019-04-05
maria-teresia.svanvik@gu.se
Date
2019-03-14Author
Svanvik, Teresia
Keywords
Endometrial cancer
relative survival
DNA ploidy
s-phase fraction
p53
socioeconomic inequality
early detection
Publication type
Doctoral thesis
ISBN
978-91-7833-384-4 (PRINT)
978-91-7833-385-1 (PDF)
Language
eng